chr12-47995240-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001844.5(COL2A1):​c.762+15G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.332 in 1,606,170 control chromosomes in the GnomAD database, including 95,544 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 6384 hom., cov: 32)
Exomes 𝑓: 0.34 ( 89160 hom. )

Consequence

COL2A1
NM_001844.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.133
Variant links:
Genes affected
COL2A1 (HGNC:2200): (collagen type II alpha 1 chain) This gene encodes the alpha-1 chain of type II collagen, a fibrillar collagen found in cartilage and the vitreous humor of the eye. Mutations in this gene are associated with achondrogenesis, chondrodysplasia, early onset familial osteoarthritis, SED congenita, Langer-Saldino achondrogenesis, Kniest dysplasia, Stickler syndrome type I, and spondyloepimetaphyseal dysplasia Strudwick type. In addition, defects in processing chondrocalcin, a calcium binding protein that is the C-propeptide of this collagen molecule, are also associated with chondrodysplasia. There are two transcripts identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 12-47995240-C-T is Benign according to our data. Variant chr12-47995240-C-T is described in ClinVar as [Benign]. Clinvar id is 258244.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-47995240-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
COL2A1NM_001844.5 linkuse as main transcriptc.762+15G>A intron_variant ENST00000380518.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
COL2A1ENST00000380518.8 linkuse as main transcriptc.762+15G>A intron_variant 1 NM_001844.5 P1P02458-2
COL2A1ENST00000337299.7 linkuse as main transcriptc.555+15G>A intron_variant 1 P02458-1

Frequencies

GnomAD3 genomes
AF:
0.257
AC:
39032
AN:
152092
Hom.:
6382
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0681
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.253
Gnomad ASJ
AF:
0.375
Gnomad EAS
AF:
0.0112
Gnomad SAS
AF:
0.269
Gnomad FIN
AF:
0.334
Gnomad MID
AF:
0.283
Gnomad NFE
AF:
0.369
Gnomad OTH
AF:
0.274
GnomAD3 exomes
AF:
0.291
AC:
73255
AN:
251384
Hom.:
12505
AF XY:
0.300
AC XY:
40781
AN XY:
135870
show subpopulations
Gnomad AFR exome
AF:
0.0608
Gnomad AMR exome
AF:
0.231
Gnomad ASJ exome
AF:
0.365
Gnomad EAS exome
AF:
0.00832
Gnomad SAS exome
AF:
0.293
Gnomad FIN exome
AF:
0.316
Gnomad NFE exome
AF:
0.376
Gnomad OTH exome
AF:
0.311
GnomAD4 exome
AF:
0.340
AC:
494035
AN:
1453958
Hom.:
89160
Cov.:
31
AF XY:
0.340
AC XY:
246005
AN XY:
723830
show subpopulations
Gnomad4 AFR exome
AF:
0.0555
Gnomad4 AMR exome
AF:
0.236
Gnomad4 ASJ exome
AF:
0.365
Gnomad4 EAS exome
AF:
0.00474
Gnomad4 SAS exome
AF:
0.296
Gnomad4 FIN exome
AF:
0.321
Gnomad4 NFE exome
AF:
0.370
Gnomad4 OTH exome
AF:
0.311
GnomAD4 genome
AF:
0.256
AC:
39039
AN:
152212
Hom.:
6384
Cov.:
32
AF XY:
0.254
AC XY:
18873
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.0679
Gnomad4 AMR
AF:
0.254
Gnomad4 ASJ
AF:
0.375
Gnomad4 EAS
AF:
0.0114
Gnomad4 SAS
AF:
0.269
Gnomad4 FIN
AF:
0.334
Gnomad4 NFE
AF:
0.369
Gnomad4 OTH
AF:
0.273
Alfa
AF:
0.308
Hom.:
1848
Bravo
AF:
0.241
Asia WGS
AF:
0.163
AC:
570
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Stickler syndrome type 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Type II Collagenopathies Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.0
DANN
Benign
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10875716; hg19: chr12-48389023; API